XSpray Pharma AB (XSPRAY) — Cash Flow Reinvestment Rate
Latest as of September 2017:
138.93x
XSpray Pharma AB (XSPRAY) has a Cash Flow Reinvestment Rate of 138.93x as of September 2017, reinvesting Skr6.39 Million (capex Skr6.39 Million ) from operating cash flow of Skr46.00K. Check XSPRAY cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
138.93x
(Capex + Investments) / Operating CF
Total Reinvested
Skr6.39 Million
Capex + Investments
Operating Cash Flow
Skr46.00K
SEK
Capital Expenditures
Skr6.39 Million
SEK
Annual Cash Flow Reinvestment Rate for XSpray Pharma AB (None–None)
Year-by-year capital reinvestment analysis for XSpray Pharma AB. For live market cap and broader valuation context, see XSPRAY stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow